©The Author(s) 2024.
World J Orthop. Oct 18, 2024; 15(10): 918-931
Published online Oct 18, 2024. doi: 10.5312/wjo.v15.i10.918
Published online Oct 18, 2024. doi: 10.5312/wjo.v15.i10.918
Table 2 Reprogramming methods of urine-derived stem cells
| Reprogramming method | Vectors | Factors | Ref. |
| SeV | SeV | OSKM | [15,43,44,48,49,58,60,63,71] |
| OCT4, SOX2, NANOG, LIN28 | |||
| JDP2, JHDM1B, MKK6, GLIS1, NANOG, ESSRB, SALL4 | |||
| Exogenous plasmids | Epi | KLD4, MYC, OCT4, SOX2, LIN28, shP53 | |
| OCT4, SOX2, KLF4, miR-302-367 | |||
| OCT4, SOX2, NANOG, LIN28, KLF4 and MYC | [85,86] | ||
| OCT4, SOX2, SV40 LT, KLF4 and miR302-367 | |||
| OCT4, SOX2, NANOG, MYC, KLF4, LIN28 | |||
| OCT4, SOX2, KLF4, and miR-302-367 | |||
| pCXLE-hOCT4-shP53-F, pCXLE-hSK, pCXLE-h UL | OSKM, shP53, LIN28 | ||
| TET-ON-induced expression vector | OSKM | ||
| pEP4EO2SET2K | OCT4, SOX2, SV40 LT and KLF4, miR-302b, c, a, d and miR-367 | ||
| SM | Cyclic pifithrin-a, A-83-01, CHIR99021, thiazovivin, NaB, PD0325901 | ||
| mRNA | OSKM LNg | ||
| srRNA | OSKM, NSP 1-4 | ||
| Lentivirus | Lentiviral vectors | OSKM |
- Citation: Yang HS, Zheng YX, Bai X, He XY, Wang TH. Application prospects of urine-derived stem cells in neurological and musculoskeletal diseases. World J Orthop 2024; 15(10): 918-931
- URL: https://www.wjgnet.com/2218-5836/full/v15/i10/918.htm
- DOI: https://dx.doi.org/10.5312/wjo.v15.i10.918